Bibliographic Details
| Title: |
Overall survival (OS) and pathologic response rate from a phase II clinical trial of neoadjuvant GVAX pancreas vaccine (with cyclophosphamide) in combination with nivolumab and stereotactic body radiation therapy (SBRT) followed by definitive... |
| Authors: |
Agarwal, Parul, Qi, Hanfei, Munjal, Kabeer, Gai, Jessica, Ferguson, Anna, Parkinson, Rose, Harrison, Jeanne, Rodriguez, Christina, Anders, Robert A., Thompson, Elizabeth D., Burkhart, Richard, He, Jin, Narang, Amol, De Jesus-Acosta, Ana, Zheng, Lei, Jaffee, Elizabeth M., George, Ben, Laheru, Daniel A., Yarchoan, Mark, Osipov, Arsen |
| Source: |
Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, pe16309-e16309, 1p |
| Database: |
Supplemental Index |
